{"id":586,"date":"2020-04-19T09:32:38","date_gmt":"2020-04-19T13:32:38","guid":{"rendered":"https:\/\/businesspartners2convince.org\/?post_type=resource&#038;p=586"},"modified":"2021-03-30T16:26:53","modified_gmt":"2021-03-30T20:26:53","slug":"bayer-contributes-medicine-supplies-knowledge-and-financial-support-to-the-global-fight-against-covid-19","status":"publish","type":"resource","link":"https:\/\/businesspartners2convince.org\/resource\/bayer-contributes-medicine-supplies-knowledge-and-financial-support-to-the-global-fight-against-covid-19\/","title":{"rendered":"Bayer Contributes Medicine, Supplies, Knowledge &#038; Financial Support to Global Fight Against COVID-19"},"content":{"rendered":"<p><strong>Quick Summary<\/strong>:<\/p>\n<p><em>Bayer is focusing on employees\u2019 health, maintaining products\u2019 supply and\u00a0providing governments, health authorities and municipalities with urgently needed medicines, medical supplies, expertise and financial assistance.<\/em><\/p>\n<p><em>Bayer will work with non-profit organizations, including Direct Relief and Feeding America, who have direct interactions with Americans who have limited access or financial means to secure health and wellness products during the COVID-19 pandemic.\u00a0<\/em><\/p>\n<h3>Contributions in Fight Against COVID-19<\/h3>\n<p class=\"\">The coronavirus presents the world with major challenges. Bayer is active in the areas of health and nutrition and has been working to provide substantial help in overcoming the crisis with their products and expertise.<\/p>\n<p class=\"\">Bayer has made significant contributions to \u00a0the fight against COVID-19 by donating medicines, medical supplies, knowledge and financial aid. \u201cExtraordinary circumstances call for extraordinary levels of support, and we will deliver,\u201d said Werner Baumann, CEO of Bayer AG. \u201cYou can count on each and every one of us at Bayer. Guided by our purpose \u2013 Science for a better life \u2013 we will do whatever it takes to help serve the world\u2019s health and nutritional needs both during and after this crisis.\u201d<\/p>\n<p class=\"\">Bayer is focusing on three areas to assist in during this crisis:<\/p>\n<h3><a href=\"https:\/\/www.bayer.com\/en\/letter-werner-baumann.aspx\">Employees\u2019 health:<\/a><\/h3>\n<ul data-rte-list=\"default\">\n<li>\n<p class=\"\">The safety and health of Bayer\u2019s employees is the top priority. As the coronavirus presents a serious risk, \u00a0the company has taken the necessary steps to limit its spread.<\/p>\n<\/li>\n<li>\n<p class=\"\">Bayer is frequently updating\u00a0 its employees on the latest developments. \u00a0The enterprise has posted advice on what everyone can do to prevent the virus from spreading on their intranet.<\/p>\n<\/li>\n<li>\n<p class=\"\">All employees can work from home until further notice, if their duties allow.<\/p>\n<\/li>\n<li>\n<p class=\"\">Bayer will assess on a case-by-case basis whether Bayer employed healthcare professionals who wish to volunteer in their communities to help fight the pandemic can temporarily be released from work while the company continues to pay their wages.<\/p>\n<\/li>\n<\/ul>\n<h3><a href=\"https:\/\/www.bayer.com\/en\/letter-werner-baumann.aspx\">Maintaining the supply of their products:<\/a><\/h3>\n<ul data-rte-list=\"default\">\n<li>\n<p class=\"\">Bayer is working at full steam to ensure business continuity so that it can provide hospitals, doctors, patients, consumers and farmers with the products they urgently need at this time.<\/p>\n<\/li>\n<li>\n<p class=\"\">Bayer has comprehensive emergency response plans prepared for all its sites which will be implemented as necessary to ensure that their facilities continue to operate safely and effectively.<\/p>\n<\/li>\n<\/ul>\n<p class=\"\">Bayer is providing governments, health authorities and municipalities with urgently needed medicines, medical supplies, expertise and financial assistance:<\/p>\n<ul data-rte-list=\"default\">\n<li>\n<p class=\"\"><a href=\"https:\/\/media.bayer.com\/baynews\/baynews.nsf\/id\/Bayer-partners-Population-Health-Research-Institute-PHRI-global-clinical-research-evaluating-COVID\">Bayer is working with other pharmaceutical companies, institutions and universities<\/a> to search for a new active substance to treat COVID-19. \u00a0Bayer is providing access to its large substance library and conducting screening work to find a potential active ingredient as part of the <a href=\"https:\/\/www.gatesfoundation.org\/Media-Center\/Press-Releases\/2020\/03\/Life-Science-Companies-Commit-to-the-Fight-Against-COVID-19-Pandemic-alongside-Gates-Foundation\">COVID-19 Therapeutic Accelerator Initiative of the Bill &amp; Melinda Gates Foundation<\/a> and is contributing to the search for an active substance to treat COVID-19 as part of the Innovative Medicines Initiative (IMI).<\/p>\n<\/li>\n<li>\n<p class=\"\">Bayer has made several large donations to hardest hit countries.\u00a0 <a href=\"https:\/\/www.magazine.bayer.com\/en\/i-feel-lucky-that-i-m-not-fighting-alone.-.aspx\">Bayer has donated medicines and additional financial aid worth a total of approximately\u00a0 1.5 million euros to support the population affected by the outbreak of the novel virus in China.<\/a> \u00a0The company has donated <a href=\"https:\/\/media.bayer.com\/baynews\/baynews.nsf\/id\/2020-0086-e\">1 million euros to an aid fund in Italy<\/a> that will be used to buy urgently needed supplies for intensive care units and protective equipment. Additionally, Bayer has <a href=\"https:\/\/www.media.bayer.com\/baynews\/baynews.nsf\/id\/Bayer-supports-fight-against-corona-pandemic-Spain-with-measures-totaling-approximately-EUR-1?\">donated \u20ac800,000 to the national health system in Spain<\/a> for the purchase of\u00a0 needed medical equipment and hospital beds, <a href=\"https:\/\/www.media.bayer.com\/baynews\/baynews.nsf\/id\/Bayer-to-donate-EUR-1-million-to-support-the-fight-against-the-coronavirus-pandemic-in-France?\">and donated 2 million euros to help fight Covid-19 in France<\/a> and <a href=\"https:\/\/media.bayer.com\/baynews\/baynews.nsf\/id\/Bayer-to-donate-EUR-1-million-to-support-the-fight-against-COVID-19-in-Brazil?Open&amp;parent=Presskit-Corona&amp;ccm=001&amp;presskit=1\">Brazil<\/a>.<\/p>\n<\/li>\n<li>\n<p class=\"\">In response to new data from initial research conducted in China that shows potential for the use of Resochin in treating COVID-19 patients, <a href=\"https:\/\/bayer2019tf.q4web.com\/news\/news-details\/2020\/Bayer-Partners-with-US-Government-on-Major-Product-Donation-to-Fight-Coronavirus\/default.aspx\">Bayer has donated 3 million tablets of the drug to the U.S. Government<\/a>, <a href=\"https:\/\/www.media.bayer.com\/baynews\/baynews.nsf\/id\/Bayer-to-donate-one-million-tablets-of-chloroquine-for-use-in-Italy?Open&amp;parent=news-overview-category-search-en&amp;ccm=020\">1 million chloroquine tablets to Italy<\/a>, and <a href=\"https:\/\/media.bayer.com\/baynews\/baynews.nsf\/id\/Bayer-donates-8-million-chloroquine-tablets-to-the-German-Federal-Government\">8 million tablets of chloroquine to the German government<\/a>.<\/p>\n<\/li>\n<li>\n<p class=\"\">Bayer Consumer Health is donating 1 million Health and Wellness Products including, Aleve, Alka-Seltzer Plus, Bayer Aspirin, Claritin, Flintstones and One-A-Day Vitamins to support the health of underserved communities. Bayer will work with non-profit organizations, including Direct Relief and Feeding America, who have direct interactions with Americans who have limited access or financial means to secure health and wellness products during the COVID-19 pandemic.<\/p>\n<\/li>\n<li>\n<p class=\"\">Bayer employees in Missouri are making face masks with 3D printers<a name=\"CHEVRON\"><\/a> to be donated to local hospitals.<\/p>\n<\/li>\n<li>\n<p class=\"\">Bayer is in the process of offering PCR testing hardware from its inventory to hospitals and is also planning to repurpose some of their R&amp;D sites to offer high volumes of PCR testing in its laboratories.<\/p>\n<\/li>\n<li>\n<p class=\"\">Bayer has also started to produce disinfectant agents at large scale in select R&amp;D sites.<\/p>\n<\/li>\n<\/ul>\n<hr \/>\n","protected":false},"featured_media":639,"parent":0,"menu_order":0,"template":"","resource_category":[9],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/businesspartners2convince.org\/wp-json\/wp\/v2\/resource\/586"}],"collection":[{"href":"https:\/\/businesspartners2convince.org\/wp-json\/wp\/v2\/resource"}],"about":[{"href":"https:\/\/businesspartners2convince.org\/wp-json\/wp\/v2\/types\/resource"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/businesspartners2convince.org\/wp-json\/wp\/v2\/media\/639"}],"wp:attachment":[{"href":"https:\/\/businesspartners2convince.org\/wp-json\/wp\/v2\/media?parent=586"}],"wp:term":[{"taxonomy":"resource_category","embeddable":true,"href":"https:\/\/businesspartners2convince.org\/wp-json\/wp\/v2\/resource_category?post=586"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}